COMPREHENSIVE PGx TESTING
Across 13 Therapeutic Indications
From Guesswork to Precision with Mira Precision PGx
Pharmacogenomics (PGx) is the study of how a person’s genes affect their response to medications. Mira Precision PGx goes beyond the standard mental health PGx tests, offering a comprehensive analysis across 13 therapeutic indications. Our advanced precision medicine solution helps providers personalize treatment plans by selecting the most effective drugs and doses for each
individual patient.
Critical Safety Insights: Uncover Gene-Drug Interactions
with Mira Precision PGx
Enhance Treatment Precision
Comprehensive PGx testing tailors medication plans to a patient’s genetic profile, improving outcomes by selecting the most effective drugs and dosages, and reducing trial-and-error.1,2
Reduce Adverse Drug Reactions
PGx testing significantly reduces adverse drug reactions (ADRs), especially in vulnerable populations like those in long-term care, by tailoring treatment plans to individual genetic profiles.1,3
Improve Cost-Effectiveness & Healthcare Savings
PGx testing offers long-term savings by reducing adverse drug reactions and hospitalizations, saving up to ~$4,000 per patient annually, making it a valuable investment for healthcare providers.1,4
- Pharmacogenomics in practice: a review and implementation guide(2023). Retrieved from https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2023.1189976/full
- Mayo Clinic. (n.d.). Pharmacogenomics for Patients – Center for Individualized Medicine. Retrieved from https://www.mayo.edu/research/centers-programs/center-individualized-medicine/patient-care/pharmacogenomics/patients
- National Institutes of Health. (n.d.). What is pharmacogenomics? Retrieved from https://ghr.nlm.nih.gov/primer/genomicresearch/pharmacogenomics
- U.S. Department of Veterans Affairs. (2023). Pharmacogenomic Testing in Mental Health Care. Retrieved from https://www.research.va.gov/topics/pharmacogenomics.cfm
Over 200 Medications Identified with Potential
Gene-Drug Interactions and Black Box Warnings.
Discover the transformative potential of Mira Precision PGx, a comprehensive pharmacogenomics test that identifies gene-drug interactions across a wide range of 13 therapeutic areas.
By understanding these interactions, clinicians can tailor treatments to individual genetic profiles, enhancing efficacy and safety. Mira Precision PGx reduces the trial-and-error approach in prescribing, leading to better patient outcomes and safety.
Source:1 National Center for Biotechnology Information. (2023). Gene-Drug Interactions. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11069364/
CPIC GUIDELINES
The Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines help clinicians understand how to use genetic test results to optimize drug therapy, rather than whether the tests should be ordered. As pre-emptive genotyping becomes more common, clinicians will increasingly encounter patient genotypes even without specific drug tests, enabling more informed treatment decisions.
Click here to view CPIC Genes-Drugs
FDA TABLE OF PGx ASSOCIATIONS
Pharmacogenetic tests, as outlined by the FDA, can guide drug therapy by helping healthcare providers tailor treatments. By considering a patient’s genotype, clinicians can adjust dosages, optimize therapeutic strategies, and evaluate the potential for benefit or toxicity, ensuring more personalized and effective care.
Click here to view The FDA Table of PGx Drugs
It is critical to identify gene-drug interactions, such as those involving CYP2C19, to improve drug safety. By recognizing genetic factors that affect drug metabolism, Pharmacogenomic Testing (PGx) can offer personalized insights to minimize adverse drug reactions and align treatments more closely with each patient’s unique genetic profile.
Rajendran Y., et al., A Longitudinal Analysis of Black Box Warnings: Trends and Implications for Drug Safety. Cureus. 2024
By identifying medications with potential gene-drug interactions, Mira Precision PGx minimizes the guesswork in prescribing, ensuring safer and more effective patient treatments.
Oncology
Personalize cancer treatments to improve outcomes and minimize side effects.
Cardiology
Optimize heart disease therapies for better patient responses.
Psychiatry
Select the most effective mental health medications, reducing trial and error.
Neurology
Customize treatments for neurological conditions like epilepsy and Parkinson’s.
Gastroenterology
Enhance therapies for gastrointestinal disorders.
Endocrinology
Adjust treatments for diabetes and hormonal disorders.
Rheumatology
Improve management of autoimmune and inflammatory diseases.
Respiratory
Tailor therapies for asthma and COPD.
Infectious Diseases
Optimize antibiotic and antiviral treatments.
Pain Management
Personalize pain relief strategies.
Urology
Customize treatments for urological conditions.
Dermatology
Enhance skin condition therapies.
Hematology
Personalize treatments for blood disorders.